genedrive plc announced that the Genedrive MT-RNR1 ID Kit is in process for roll out at two further hospital sites in the North West NHS. The implementation project, scheduled to commence from April, will follow the NICE final recommendation for the use of the Genedrive MT-RNR1 ID test in the NHS which is due towards the end of this month. The Manchester Academic Health Science Centre Women and Children Domain, part of Health Innovation Manchester are supporting and project managing the further roll out across Manchester University NHS Foundation Trust.

The Company continues to work alongside HInM on specific plans for the roll out across an additional five neonatal sites in Greater Manchester. Once fully subscribed at this regional level, the test would be available when needed to circa 30000 newborns over the next NHS fiscal year, of which 10-12% are modelled to be admitted to a regional neonatal unit. HInM is one of eight national centres designated by NHS England and the National Institute for Health and Care Research for demonstrating excellence in patient care and driving innovation into the health service.